Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_provenance.
- NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_assertion description "[Finally, this study indicates that serous cystadenocarcinomas may be suitable tumours for MAGE-1 peptide immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_provenance.
- NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_assertion evidence source_evidence_literature NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_provenance.
- NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_assertion SIO_000772 9743307 NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_provenance.
- NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_assertion wasDerivedFrom befree-20150227 NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_provenance.
- NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_assertion wasGeneratedBy ECO_0000203 NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_provenance.
- befree-20150227 importedOn "2015-02-27" NP1009689.RArYxxFl7ysOIY8CXwWHKVfIW0ic8uT_BwqahcSU_fcds130_provenance.